Sunshine Biopharma (SBFMW) Finished Goods (2019 - 2020)
Sunshine Biopharma (SBFMW) reported Finished Goods of $23771.0 for Q4 2020, up 49.41% on a YoY basis from $15910.0 in Q1 2020, and up 49.41% quarter-over-quarter from $15910.0 in Q4 2019.
Sunshine Biopharma (SBFMW) Finished Goods (2019 - 2020) Analysis & Trends
Sunshine Biopharma has reported Finished Goods for 2 years, with the latest figure at $23771.0 in Q4 2020.
- For the quarter ending Q4 2020, Finished Goods rose 49.41% year-over-year to $23771.0; the trailing twelve-month figure through Dec 2020 stood at $23771.0 (up 49.41% YoY), and the FY2020 full-year result was $23771.0, up 49.41% from the prior year.
- Finished Goods for Q4 2020 stood at $23771.0, up from $15910.0 in the prior quarter.
- The five-year high for Finished Goods was $23771.0 in Q4 2020, with the low at $15910.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn |
| 10 | Sunshine Biopharma | - | - | 2.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 23,771.00 |
| Dec 31, 2019 | 15,910.00 |